Novel genetic markers improve measures of atrial fibrillation risk prediction

Brendan M. Everett(Cedars-Sinai Medical Center), Christine M. Albert(Cedars-Sinai Medical Center), Daniel I. Chasman(Brigham and Women's Hospital), David Conen(Yamaha (Japan)), Nancy R. Cook(Brigham and Women's Hospital), Paul M. Ridker(Herlev Hospital)
European Heart Journal
February 26, 2013
10.1093/eurheartj/eht033
Cited by 141

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Biological, clinical and population relevance of 95 loci for blood lipids
|Nature|2010|3.7k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k